Evidence map›Paper›PMID 42232090›Full record

ArticleEpilepsy & behavior reports2026

Centroparietal periodic sharp-wave discharges and biphasic complexes: Novel EEG biomarkers for early diagnosis of Rasmussen encephalitis.

Philippe Gélisse, Pierre Genton, Arielle Crespel

Abstract readCase Reports
In one paragraph

Article in Epilepsy & behavior reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Philippe GélisseEpilepsy Unit, Gui de Chauliac Hospital, Montpellier, France.
Pierre GentonNeurology Department, Hôpital Saint Charles, 13100 Aix en Provence, France.
Arielle CrespelEpilepsy Unit, Gui de Chauliac Hospital, Montpellier, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Rasmussen encephalitis (RE) is a rare, chronic inflammatory brain disorder that predominantly affects one hemisphere in children. It is characterized by progressive neurological deterioration and refractory seizures. Early diagnosis remains challenging due to nonspecific initial symptoms and diagnostic features that overlap with other neurological conditions. Objective: To identify early and specific EEG patterns that may support timely initiation of immunomodulatory therapies. Method: Continuous long-term video-EEG monitoring was repeatedly conducted in a female patient who experienced her first seizures at age 16, soon after a febrile illness. Results: Identification of two distinctive EEG patterns-focal periodic sharp-wave discharges and biphasic complexes-allowed early diagnosis prior to the onset of severe deficits or epilepsia partialis continua. The biphasic complexes occurred alongside unilateral slow-wave activity, whereas focal periodic sharp-wave discharges were initially observed on an otherwise normal background. The biphasic complexes appear to herald evolution to the acute phase of the disease. Prompt immunomodulatory therapy (intravenous immunoglobulin followed by adalimumab) successfully halted disease progression, nearly normalized EEG background activity, and reduced seizure frequency. Conclusions: This case underscores the prognostic value of recurrent focal periodic sharp-wave discharges and biphasic complexes as prodromal EEG biomarkers for RE, aligning with one prior study linking these biphasic complexes to early-stage disease (Beaumanoir et al., 1997). Early recognition of these patterns is essential. Early initiation of immunotherapy may prevent irreversible neurological damage, highlighting the critical role of recognizing these electrographic patterns for timely diagnosis and intervention.

Indexed as

AdalimumabDrug-resistanceElectroencephalogramFocal seizuresImmunotherapyRasmussen syndrome

Identifiers

PMID42232090
PMCPMC13223952

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.